Clear Harbor Asset Management, LLC Bausch Health Companies Inc. Transaction History

Clear Harbor Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	BUY	$7.06 - $23.63 $70,600 - $236,300	10,000 New	10,000 $84,000
Q4 2021 Jan 21, 2022	SELL	$23.0 - $29.01 $455,975 - $575,123	-19,825 Closed	0 $0
Q3 2021 Nov 03, 2021	SELL	$25.04 - $30.06 $82,006 - $98,446	-3,275 Reduced 14.18%	19,825 $552,000
Q2 2021 Aug 06, 2021	BUY	$27.43 - $32.7 $337,389 - $402,210	12,300 Added 113.89%	23,100 $679,000
Q4 2020 Feb 04, 2021	BUY	$15.31 - $21.12 $165,348 - $228,096	10,800 New	10,800 $224,000
Q1 2020 May 08, 2020	SELL	$12.98 - $30.25 $47,052 - $109,656	-3,625 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$18.89 - $31.89 $68,476 - $115,601	3,625 New	3,625 $108,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Clear Harbor Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Harbor Asset Management, LLC with notifications on news.